СПИСОК ЛИТЕРАТУРЫ
1. Аганина, Е.Н. Комплексное использование повязок Silkofix professional в практике комбустиолога [Электронный ресурс] / Е.Н.Аганина, О. Л. Ведерникова // Комбустиология. - 2013.
- № 49-50. - Режим доступа: http ://combustiolog.ru/j oumal/razdel-3 -voprosy-regenerativnoj -meditsiny-v- kombustiologii/2. Аганина, Е.Н. Повязки Povi Silkofix в лечении ожогов [Электронный ресурс] / Е. Н. Аганина, О. Л. Ведерникова // Комбустиология. -2011,- № 46- 47. - Режим доступа: http://combustiolog.ru/iournal/razdel-5-mestnoe-lechenie- ozho go v-konservativny-e-metodv/
3. Алексеев, А. А. Местное использование антимикробных средств для
лечения ожоговых ран [Электронный ресурс] / А. А. Алексеев, А. Э. Бобровников, М. Г. Крутиков // Комбустиология. - 2011. - № 45. - Режим доступа: http ://combustiolo g.ru/i ournal/mestnoe-ispol-zovanie-antimikrobny-h-
sredstv-dlva-lecheniya-ozhogow-h-ran/
4. Алексеев, А. А. Профилактика и лечение послеожоговых рубцов силиконсодержащими повязками мепиформ [Электронный ресурс] / А. А. Алексеев, А. Э. Бобровников, А. Б. Акименко // Комбустиология. - 2008,- № 34. - Режим доступа: http://combustiolog.ru/journal/profilaktika-i-lechenie- posleozhogovy-h-rubtsov-silikonsoderzhashhimi-povyazkami-mepiform/
5. Влияние местного применения интерлейкина 1[3 на цитологические параметры заживления кожной раны / Е.А. Варюшина, В.Л. Розломий, Е.В. Александров и др. // Цитокины и воспаление. - 2010. - №2. - С. 7-12.
6. Зубов, Д. А. Цитокиновая иммунорегуляция репаративной регенерации костной ткани культивированными мезенхимальными стволовыми клетками / Д. А. Зубов, В. М. Оксимец // Травма. - 2008. - Т.9. - №2. - С. 145-153.
7. Коржевский, Д.Э. Основы гистологической техники / Д.Э. Коржевский, А.В. Еиляров. - СПб. : СпецЛит, 2010. - 95с.
8. Куценко С. А. Экспериментальная оценка эффективности препаратов арники: крем «Арнилек», гель «Арнилек», линимент «Арнилек» при механических, термических и лучевых поражениях кожи / С.
А. Куценко, М. В. Данилив, В.А Башарин и др. // Фармакология. - 2007. - Т. 8. - №2. - С. 579-615.9. Макоев, С.Н. Лазерная фотодинамическая терапия ожоговых ран (экспериментальное исследование): дисс. ... канд. мед. наук / С. Н. Макоев. - Москва, 2009. - 24 с.
10. Ожоги [Электронный ресурс]. Информационный бюллетень ВОЗ №365. -2014. - URL: http://www.who.int/mediacentre/factsheets/fs365/ru/
11. Комбустиология / Э.Я. Фисталь, Г.П. Козинец, Г.Е. Самойлоенко и др. - Донецк.: ДонНМУ им. Горького, 2005. - 272 с.
12. Патогенез типовых реакций организма на травму / Н.П. Чеснокова, П.В. Глыбочко, В.Ю. Барсуков и др. - Саратов: Изд-во СМУ, 2011. - 230 с.
13. Пономарева Н.А., Воробьев А.В., Жегалов В.А., Перетяган С.Н. История и этапы развития комбустиологической службы в России //Здравоохранение Российской Федерации. 2009. №6. С. 45-48
14. Применение биологической повязки «Ксенодерм» при лечении
ожоговых ран [Электронный ресурс] / А. А. Алексеев, Ю. И. Тюрников, С. В. Попов, А. Э. Бобровников // Комбустиология. - 2007. - № 32-33. - Режим доступа: http://combustiolog.ru/journal/primenenie-biologicheskoj-povyazki-
ksenoderm-pri-lenchenii-ozhogovy-h-ran/
15. Расулов М.Ф. Использование мезенхимальных стволовых клеток костного мозга и эмбриональных фибробластов печени в лечении ожоговых ран / М.Ф. Расулов // Тихоокеанский медицинский журнал. - 2004. - № I, С. 7-9.
16. Секреция паракринных факторов стимулированными аналогом аденозина дендритными клетками человека / К.В. Горемыкин, К.С. Юрьева, Ю.А. Яковлева и др. // Науки о человеке: сб. статей по материалам XII
Российского конгресса молодых ученых с международным участием / СибГМУ. - Томск, 2011. - С. 21-23.
17. Современные методы клеточной терапии при лечении ожогов / С. В. Смирнов, И. В. Киселев, А. В. Васильев, В. В. Терских // Хирургия. - 2002. - № 12. - С. 58-62.
18. A comparative analysis of advanced techniques for skin reconstruction with autologous keratinocyte culture in severely burned children: own experience / A.
Chrapusta, M. B. Nessler, J. Dmkala et al. // Postepy. Dermatol. Alergol. - 2014. - Vol. 31, N 3. - P. 164-169.19. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Tolerability of a 14 Day Treatment Course of GW493838 50mg Compared to Placebo in Subjects with Peripheral Neuropathic Pain [Electronic resource] / URL: http://www.gsk- clinicalstudyregister.com/study/Al A20004#ps
20. A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis / T. Yang, Z. Wang, F. Wu et al. // PLOS computational biology. - 2010. - Vol. 6. - P. 1-7.
21. Al adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes / A. N. Clark, R. Youkey, X. Liu et al // Circ. Res. - 2007. -V. 101. -P. 1130-1138.
22. A2B adenosine receptors in immunity and inflammation / G. Hasko, B. Csoka, Z. H. Nemeth et al. // Trends Immunol. - 2009. - Vol. 30. - P. 263-270.
23. A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice / H. W. Young, J. G. Molina, D. Dimina, et al. // J. Immunol. - 2004. - Vol. 173. - P. 1380 - 1389.
24. A3 Adenosine Receptors Modulate Eosinophil Function In Bleomycin- Induced Lung Injury / E. Morschl, J.B. Volmer, J.G. Molina et al. // J. Allerg. Clin. Immunol. - 2007. - Vol 119, N I. - S218
25. A3 adenosine receptor: pharmacology and role in disease / P. A. Borea, S. Gessi, S. Bar-Yehuda, P. Fishman // Handb. Exp. Pharmacol. - 2009. - Vol. 193. - P. 297-327.
26. ABT-702 an adenosine kinase inhibitor, attenuates in diabetic inflammation retinopathy / N. M. Elsherbiny, S. Ahmad, M. Naime et al. // Life Sci. - 2013. - Vol 93, N 2-3.-P. 78-88.
27. Action of adenosine at its receptors in the CNS: insights from knockouts and drugs / B.B. Fredholm, J. Chen, S. A. Masino et al. // Ann. Rev. of Tharmacol. And Toxicolog. - 2005. - Vol. 45. - P. 385-412.
28.
Activation of A2A adenosine receptors inhibits expression of alpha 4/beta I integrin (very late antigen-4) on stimulated human neutrophils / G. W. Sullivan,D. D. Lee, W. G. Ross et al. // J. Leukoc. Biol. - 2004. - Vol. 5. - P. 127-134.
29. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents / G. J. Chen, В. K. Harvey, H. Shen et al. // J. Neurosci. Res. - 2006. - Vol. 84, N 8. - P. 1848-1855.
30. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation / C. McLeod, A. Bagust, A. Boland et al. // Health Technol. Assess. - 2007. - Vol. 11, N 28. - P. 1-158.
31. Adenosine Al receptors and microglial cells mediate CX3 CL I-induced protection of hippocampal neurons against Glu-induced death / C. Lauro, R. Cipriani, M. Catalano et al. // Neuropsychopharmacology. - 2010. - Vol. 35, N 7. -P. 1550-1559.
32. Adenosine A2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis / M.C. Montesinos, J. P. Shaw, H. Yee et al. // Am. J. Pathol. - 2004. - Vol. 164, N 6. - P. 1887-1882.
33. Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system / P.E. Lazzerini, M. Natale, E. Gianchecchi et al. // J. of Mol. Med. - 2012. - Vol. 90, N 3. - P. 331-342.
34. Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities / S. Morello, R. Sorrenrino, A. Pinto // Journal of receptor, ligand and channel research. - 2009. - Vol. 2. - P. 11-17.
35. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway / P. M. Cams, L. 0. Porciuncula, G. M. Cunha et al. // J. Neurosci.
- 2009. - Vol. 29, N 47. - P. 14741-14751
36. Adenosine A2A receptor is a unique angiogenic target of HIF-2a in pulmonary endothelial cells / A.
Ahmad, S. Amad, L. Glover et al. // Proceedings of the National Academy of Sciences. - 2009. - Vol. 106, N 26. - P. 10684-10689.37. Adenosine A2a receptor stimulation increases angiogenesis by downregulating production of the antiangiogenic matrix protein thrombospondin I / A. Desai, C. Victor-Vega, S. Gadangi et al. // Mol. Pharmacol. - 2005. - Vol. 67. - P. 1406-1413.
38. Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PB-kinase and ERKI/2 pathways / A. Ahmad, J.B. Schaack, C.W. White, S. Ahmad // Biochem. Biohys. Res. Commun. - 2013. - Vol. 434, N 3. - P. 566-571.
39. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma / E. S. Chan, P. Fernandez, A. A. Merchant et al. // Arthritis Rheum. - 2006. - Vol. 54, N 8. - P. 2632-2642.
40. Adenosine A2A receptors promote collagen production by Flil- and CTGF
- mediated mechanism / E. S. Chan, H. Liu, P. Fernandez et al. // Arthritis Res. And Ther. - 2013. - Vol. 15 - P. 58.
41. Adenosine A2Areceptor activation attenuates inflammation and injury in diabetic nephropathy / A.S. Awad, L. Huang, H. Ye et al. // Am. J. Physiol. Renal. Physiol. - 2006. - Vol. 290. - P. 828-837.
42. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells /
E. Panther, S. Corinti, M. Idzko et al. // Blood. - 2003. - Vol. 101, N. 10. - P. 3985-3990.
43. Adenosine and methotrexate polyglutamate concentration in patients with juvenile arthritis / P. Dolezalova, J. Krijt, J.Chadek et al. // Rheumatology. - 2005. -Vol. 44, NI. -P. 74-79.
44. Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease / D. J. Schneider, J. C. Lindsay, Y. Zhou et al. // FASEB J. - 2010. - Vol. 24. - P. 70-80.
45. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells / E.
Hashimoto, K. Kage, T. Ogita et al. // Biochem. Biophys. Res. Commun. - 1994. - Vol. 204. - P. 318-324.46. Adenosine Augments IL-IO Production by Macrophages through an A2BReceptor-Mediated Posttranscriptional Mechanism / Z. H. Nemeth, C. S. Lutz, B. Csoka et al. // J. Immunol. - 2005. - Vol. 175, N 12. - P. 8260-8270.
47. Adenosine induces apoptosis by inhibiting mRNA andprotein synthesis in chick embryonic sympathetic neurons / J. S. Kulkarni, D. A. Przywara, T. D. Wakade, A. R. Wakade // Neruroscience Lett - 1998. - Vol. 248. - P. 167-190.
48. Adenosine induces cell cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines. LNcap-FGC-10, DU-145, and PC3 / M. Aghaei, F. Karami-Tehrani, M. Panjehpour et al. // Prostate. - 2012. - Vol. 72, N4.-P. 361-375.
49. Adenosine induces cell cycle arrest and apoptosis via cyclinDl/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR / S. Shirali, M. Aghaei, M. Shabani et al. // Tumor Biol. - 2013. - Vol. 32, N 2. - 1085-1095.
50. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms / G. Hasko, D. G. Kuhel, J. F. Chen et al. // FASEB J. - 2000. - Vol. 14, N 13. - P. 2065-2074.
51. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway /M. R. Blackburn, C. G. Lee, H. W. Young et al. // J. Clin. Invest. - 2003. - Vol. 112. - P. 332-344.
52. Adenosine metabolism and murine strain-specific IL-4-induced
inflammation, emphysema, and fibrosis / B. Ma, M. R. Blackburn, C. G. Lee et al. // J. Clin. Invest. - 2006. - Vol. 116. - P. 1274-1283.
53. Adenosine Modulates HIF-la, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells / S. Gessi, E. Fogli, V. Sacchetto et al. // Arterioscler. Thromb. Vase. Biol. - 2010. - V. 30. - P. 90-97.
54. Adenosine modulates LPS-induced cytokine production in porcine
monocytes / P. Ondrackova, H. Kovaru, F. Kovaru et al. // Cytokine. - 2013. - Vol. 61, N 3. - P. 953-961.
55. Adenosine promotes angiogenesis through up-regulation of
thrombospondin-1 /1/ Ernens, M. Bousquenaud, B. Lenoir et al. // Eur. Heat J. - 2013.-Vol. 34, Suppl. l.-P. 1053.
56. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A2A receptors / M. Montesinos, J. F. Chen, A. Desai et al. // Am. J. Pathol. - 2002. - Vol. 160. - P. 2000-2009.
57. Adenosine receptor signaling in the brain immune system / G. Hasko, P.
Pacher, E. S. Vizi, P. files // Trends Pharmacol. - 2005. - Vol. 26. - P. 511-516.
58. Adenosine receptor targeting in health and disease / S. Gessi, S. Merighi, D.
Fazzi et al. // Expert Opin. Investig. Drugs. - 2011. - Vol. 20. - P. 1591-1609.
59. Adenosine receptor: therapeutic aspects for inflammatory and immune diseases / G. Hasko, J. linden, B. Cronstein, P. Pacher // Nature Rev. Drug Discovery. - 2008. - Vol. 7. - P. 759-770.
60. Adenosine receptors in regulation of dendritic cell differentiation and function / S.V. Novitskiy, S. Ryzhov, R. Zaynagetdinov et al. // Blood. - 2008. - Vol. 112, N 5.-P. 1822-1831.
61. Adenosine stimulate the migration of human endothelial progenitor cells. Role of CXCR4 and MicroRNA-150 / M. Rolland-Yumer, E. Goretti, M. Bousquenaud et al. // PLOS One. - 2013. - Vol. 8, N I. - e54135.
62. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial / A. E. Iskandrian, T. M. Bateman, L. Belardinelli et al. // Nucl. Cardiol. - 2007. - Vol. 14.-P. 645-658.
63. Adenosine. A key link between metabolism and brain activity / Eds.S Masino, D. Boison. - New York.: Springer, 2013. - 680 p.
64. Adenosine-induced apoptosis in embryonic chick sympathetic neurons: a new physiological role for adenosine / T. D. Wakade, К. C. Palmer, R. McCauley at al. // J. Physiol. - 1995. - Vol. 488. - P. 123-138.
65. Adenosine-induced apoptosis in embryonic chick sympathetic neurons: a new physiological role for adenosine / T. D. Wakade, К. C. Palmer, R. McCauley at al. // J. Physiol. - 1995. - Vol. 488. - P. 123-138.
66. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis / A. Abdel-Latif, R. Bolli, I. M. Tleyjeh et al. // Arch.Intem. Med.- 2007. - Vol. 167, N 10. -P. 989-997.
67. An A2a adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models / С. C. Moore, E. N. Martin, G. H. Lee et al. // BMC Infect. Dis. - 2008. - Vol. 8. - P. 141.
68. Animal models for arthritis: innovative tools for prevention and treatment / G. Kollias, P. Papadaki, F. Apparailly et al // Ann. Rheum. Dis. - 2011. - Vol. 70. -P. 1357-1362.
69. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors / Y. Chen, R. Corriden, Y. Inoue et al. // Science. - 2006. - Vol. 314, N 5806. - P. 1792-1795.
70. Baraniak, P. Stem cell paracrine actions and tissue regeneration / P. Baraniak, T. McDevitt // Regenerative Medicine. - 2010. - Vol. 5, N I - P. 121- 143.
71. Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis / C. Lieu, J. Heymach, M. Overman et al. // Clin. Cancer Res. - 2011.-Vol. 17, N 19. -P.6130-6139
72. Blokade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias I week after myocardial in the rat model / H. Zhang, H. Zhong, T. H. Everett etal. //HeartRhythm. -2014. - Vol. 11, N I. -P. 101-109.
73. Calker, D. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells /D. Calker, M. Muller, B. Hamprecht // J. Neurochem. - 1979. - Vol. 33. - P. 999-1005.
74. CD39 and CD73 in immunity and inflammation / L. Antonioli, P. Psacher, E.S. Vizi, G. Hasko // Trends Mol. Med. - 2013. - Vol 19, N 6. - P. 355-367.
75. Cerqueira M.D. Advances in pharmacologic agents in imaging: new A2a receptor agonists / M.D. Cerqueira // Curr. Cardiol. Rep. - 2006. - Vol. 8. - P.119-122.
76. CGS 21680, an agonist of the adenosine A2Areceptor, reduces progression of murine type II collagen-induced arthritis / E. Mazzon, E. Esposito, D. Impellizzeri et al. // J. Rheumatol. - 2011. - Vol. 38. - P. 2119-2129
77. Che, J. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen- activated protein kinase signaling pathway / J. Che, E. S. Chan, B. N. Cronstein // Mol. Pharmacol. - 2007. - Vol. 72. - P. 1626-1636.
78. Chen J. Adenosine receptors as drug targets - what are the challenges? / J. Chen, H. K. Eltzschig, B.B. Fredholm // Nature Rev. Drug Discov. - 2013. - Vol. 12. -P. 265-286.
79. Chester, D. L. A review of keratinocyte delivery to the wound bed / D. L. Chester, D. S. Balderson, R. P. Papini // J. Burn Care Rehabil. - 2004. - Vol. 25. - P. 266-275.
80. Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells / F. Veglia, E. SciarafEa, A. Riccomi et al. // Infect. Immun. - 2011. - Vol. 79, N 3. - P. 1300-1310.
81. Cieslak, M. Adenosine A2A receptors in Parkinson’s disease treatment / M. Cieslak, M. Komoszynski, A. Wojtczak // Purinergic. Signal. - 2008. - Vol. 4, N 4. - P. 305-312.
82. Clinical application of cultured epithelial autografts on acellular dermal matrices in the treatment of extended burn injuries / T. Fang, W.C. Lineaweaver,
F. C. Sailes et al. // Ann. Plast. Surg. - 2014. - Vol. 73, N 5. - P. 509-515.
83. Clinical results of an autologous engineered skin / S. blames, E. Garcia, V. Garcia et al. // Cell Tissue Bank. - 2006. - Vol. 7. - P. 47-53.
84. Cordoro, К. M. TNF-alpha inhibitors in dermatology / K. M. Cordoro, S. R. Feldman // Skin Therapy Lett. - 2007. - Vol. 12. - P. 4-6
85. Cronstein B. N. Low-dose methotrexate: a mainstain in the treatment of rheumatoid arthritis / B. N. Cronstein // Pharmacol. Rev. - 2005. - Vol. 57, N 2. - P. 163-172.
86. Cronstein, B. N. Adenosine receptors and fibrosis: a translational review / B.N. Cronstein // Biol. Rep. - 2011. - Vol. 3, N I - P. 21.
87. Cultured epithelial autografts in massive bums: A single-center retrospective study with 63 patients / A. Cirodde, T. Leclerc, P. Jault et al. // Burns. - 2011. - Vol. 37, N 6. - P. 964-972.
88. Cultured human epithelium: Human umbilical cord blood stem cells differentiate into keratinocytes under in vitro conditions / L. P. Kamolz, A. Kolbus, N. Wick et al. // Burns. - 2006. - Vol. 32. - P. 16-19.
89. Cunha, R.A. Neuroprotection by adenosine in the brain: From Al receptor activation to A2Areceptor blockade / R. A. Cunha // Purinergic Signal. Jun. - 2005. -Vol. I, N 2. -P. 111-134.
90. Cyclic nucleotides promote monocyte differentiation toward a DC- SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells / D. Giordano, D. M. Magaletti, E. A. Clark, J. A. Beavo // The Journal of Immunology. - 2003. - Vol. 171, N 12. - P. 6421-6430.
91. Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2 / Mohamedali K.A., Ran S, Gomez-Manzano et al. // BMC Cancer. - 2011. - V. 11. - P. 358.
92. Dendritic cells as the terminal stage of monocyte differentiation / K. A. Palucka, N. Taquet, F. Sanchez-Chapuis, J. C. Gluckman //J. Immunol. - 1998. - Vol. 160. -P. 4587-4595.
93. Differential effects of adenosine A2a and A2b receptors on cardiac contractility / P. C. Chandrasekera, V. J. McIntosh, F. X. Cao, R. D. Lasley / Am J. Physiol. Heart Circ. Pysiol. - 2010. - Vol. 299, N 6. - P. 2082-2089
94. Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines / S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein et al. // J. Pharmacol. Exp. Ther. - 2008. - Vol. 324, N 2. - P. 694-700.
95. Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells / S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein,S. et al. // J. Immunol. - 2008. - Vol. 180. - P. 7212 - 7220.
96. Effect of artificial dermal substitute, cultured keratinocytes and split thickness skin graft on wound contraction / M. J. Reid, L. J. Currie, S. E. James, J. R. Sharpe // Wound Repair. Regen. - 2007. - Vol. 15. - P. 889-896.
97. Effect of the adenosine Ai receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects / N. J. Giffin, F. Kowacs, V. Libri et al. // Cephalalgia. - 2003. - Vol. 23. - P. 287-292.
98. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease / K. Golembiowska, J. Wardas, K. Noworyta-Sokolowska //Neurotox. Res. - 2013. -Vol. 24, N I. - P. 29-40.
99. El Tahan, M. R. Effects of aminophylline on cognitive recovery after sevoflurane anesthesia / M. R. El Tahan // J. Anesth. - 2011. Vol. 25, N 5. - P.648- 656.
100. Emerging therapy for improving wound repair of severe radiation bums using local bone marrow-derived stem cell administrations / E. Bey, M. Prat, P. Duhamel et al. // Wound Repair Regen. - 2010. - Vol. 18. - P. 50-58.
101. Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes / K. Varani, F. Vincenzi, A. Tosi et al. // Br. J. Pharmacol. - 2010. - Vol. 160. - P. 101-115.
102. Expression and regulation of HIF-Ialpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor / J. Westra, E. Brouwer, I. A. van Roosmalen, et al. // BMC Musculoskeletal Disorders. - 2010. - Vol. 11. -P. 61
103. Expression, prognostic and predictive impact of VEGF and bFGF in nonsmall cell lung cancer / F.S. Farhat, A. Tfayli, N. Fakhruddin et al. // Crit. Rev. Oncol. Hematol. - 2012. - Vol. 84, N 2. - P. 149-160.
104. Ezeamuzie, C. I. The role of adenosine A2 receptors in the regulation of TNF-a production and PGE2 release in mouse peritoneal macrophages / C. I. Ezeamuzie, I. Khan // Int. Immunopharmacol. - 2007. - Vol. 7. - P. 483-490.
105. FcepsilonRI beta-chain ITAM amplifies РІЗК-signaling to ensure synergistic degranulation response via Fcepsilon and adenosine receptors / S. Nunomura, Y. Gon, T. Yoshimaru et al. // Eur. J. Immunil. - 2010. - Vol. 40, N 4. -P. 1205-1217.
106. Fishman, P. Targeting the A3 adenosine receptor for glaucoma treatment (review) / P. Fishman, S. Cohen, S. Bar-Yehuda // Mol. Med. Rep. - 2013. - Vol. 7, N 6. - P. 1723-1725.
107. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts / Y. Chen, S. Epperson, L. Makhsudova et al. // Am. J. Circ. Physiol. - 2004. - Vol. 287, N 6, P. 2478-2486.
108. Gao, Z. G. Emerging adenosine receptor agonists / Z. G. Gao, K. A. Jacobson // Expert Opin. Emerg. Drugs. - 2007. - Vol. 12. - P. 479-492.
109. Ghahary, A. Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar / A. Ghahary, A. Ghaffari //Wound Repair. Regen. - 2007. - Vol. 15, Suppl. l.-P. 46-53.
HO. Gomez, G. Adenosine: key link between allergy and asthma? / G. Gomez // J. of Tmm. and Clin. Res. - 2013. - Vol. l.-P. 1009.
111. Gottlieb, S.S. Adenosine Ai antagonists and the cardiorenal syndrome / S.S. Gottlieb // Curr. Heart Fail Rep. - 2008. - Vol. 5. - P. 105-109.
112. Graft site malignancy following treatment of full-thickness burn with cultured epidermal autograft / C. Theopold, D. Hoeller, P. Velander et al. // Plast. Reconstr. Surg. - 2004. - Vol. 114. - P. 1215-1219.
113. Ham, J. The adenosine a2b receptor: its role in inflammation / J. Ham, D. A. Rees // Endocr. Metab. Immune Disord. Drug Targets. - 2008. - Vol. 8. - P. 244 - 254.
114. Hasko, G. A2A receptors in inflammation and injury: lessons learned from transgenic animals / G. Hasko, P. Pacher. // J. Leukoc. Biol - 2008. - Vol. 3. - P. 447-455.
115. Hasko, G. Adenosine: an endogenous regulator of innate immunity / G. Hasko, B. Cronstein // Trends in Immunology. - 2004. - Vol. 25. - P. 324 - 327.
116. Hasko, G. ATVB in Focus: The Role of Adenosine in Response to Vascular Inflammation / G. Hasko, P. Pacher // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2012. - Vol. 32. - P. 865-869.
117. Hasko, G. Regulation of macrophage function by adenosine / G. Hasko, P. Pacher // Arterioscler. Thromb. Vase. Biol. - 2012. - Vol. 32. - P.865-869.
118. Headrick, J. P. A3 Adenosine receptor-mediated protection of the ischemic heart / J. P. Headrick, J. N. Peart // Vase. Pharm. - 2005. - Vol. 42, N 5-6. - P. 271-279
119. Heart regeneration, stem cells, and cytokines / N. Li, C. Wang, L. Jia, J. Du // Regenerative medicine research. - 2014. - Vol. 2. - P.6
120. Henderson-Smart, D. J. Caffeine versus theophylline for apnea in preterm
infants [Electronic resource] / D. J. Henderson-Smart, P. A. Steer // Cochrane Database Syst. Rev.- 2010. - I. 20. - N. CD000273. - URL:
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000273.pub2/abstract
121. Hickey, P. Adenosine A2A antagonists in Parkinson's disease: what's next? / P. Hickey, M. Stacy // Curr. Neurol. Neurosci. Rep. - 2012. - Vol. 12, N. 4. - P. 376-385
122. Histamine induces the generation of monocyte-derived dendritic cells that express CD 14 but not CDla / N. Katoh, F. Soga, T. Nara et al. // J. Invest. Dermatol. - 2005. - Vol. 125, N 4. - P. 753-760.
123. Hocher, B. Adenosine Ai receptor antagonists in clinical research and development / B. Hocher // Kidney Int. - 2010. - Vol. 78. - P. 438-445
124. Horch, R. E. Tissue engineering of cultured skin substitutes / R. E. Horch, J. Kopp, U. ICneser / J. Cell Mol. Med. - 2005. - Vol. 9. - P. 592-608.
125. Horwitz, E.M. Cytokines as the major mechanism stem cell clinical activity: expanding of spectrum of cell therapy / E.M. Horwitz, W.R. Pranther // Isr. Med. Assoc. J. - 2009. - Vol. 11, N 4. - P. 209-211.
126. Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile / A.R. Elia, P. Cappello, M. Puppo et al. // Journal of Leukocyte Biology. - 2008. - Vol. 84. - P. 1472-1482.
127. Human umbilical cord blood cells form epidermis in the skin equivalent model / L. Mortier, F. Delesalle, P. Formstecher, R. Polakowska // Exp. Dermatol. - 2010. - Vol. 19. - P. 929-930
128. Hypoxia modulates adenosine receptors in human endothelial and smooth mascle cells toward an A2B angiogenic phenotype / I. Feoktistov, S.Ryzhov, H. Zhong et al. // Hypertension. - 2004. - Vol. 44. - P. 649-654.
129. 11-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CDladun, CD83+ myeloid dendritic cell subset / К. C. Roy, G. Bandyopadhyay, S. Rakshit et al. // J. of Cell. Sci. - 2004. - Vol/ 117, N 16. - P. 3435-3445.
130. Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CFlOl treatment / S. Bar-Yehuda, L. Rath-Wolfson, L. Del Valle et al. // Arthritis Rheum. - 2009. - Vol. 60, N 10. - P. 3061-3071.
131. Induction of the CXC chemokine interferon-y-inducible protein (IP)-IO regulates the reparative response following myocardial infarction / M. Bujak, M. Dobaczewski, C. Gonzalez-Quesada et al. // Circ. Res. - 2009. - V. 105, N 10. - P. 973-983.
132. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-I cells /N. D. Khoa, M. C. Montesinos, A. B. Reiss et al. // J. Tmmunol. - 2001. - Vol. 167. - P. 4026-4032.
133. Infliximab in dermatological treatment: beyond psoriasis / D. Rigopoulos, C. Korfitis, S. Gregoriou, A. D. Katsambas // Expert Opin. Biol. Ther. - 2008. - Vol. 8, N I. -P. 123-133.
134. Inhibitor of adenosine kinase attenuates inflammation and neurooxicity in traumatic optic neuropathy / S. Ahmad, N.M.Elsherbiny, K. Bhatia et al. // J. of Neuroimm. - 2014.
135. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction / J. S. Burchfield, M. Iwasaki, M. Koyanagi et al // Circ. Res. - 2008. - V. 103. - P. 203-211.
136. Interleukin-8 differentially regulates migration of tumor-assotiated and normal human brain endothelial cells / C. Charalambous, L. B. Pen, Y. S. Su et al. // Cancer Res. - 2005. - Yol. 65. - P. 10347-10354.
137. Internalization and desensitization of adenosine receptors / E. C. Klaasse, A. P. Ijzerman, W. J. de Grip, M. W. Beukers // Purinergic Signal. - 2008. - Vol. 4. - P. 21-37.
138. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors / В. B. Fredholm, A. P. Uzerman, K. A. Jacobson et al. // Pharmacol. Rev. - 2001. - Vol. 53. - P. 527 - 552.
139. Ioannidou, E. Therapeuticmodulation of growth factors and cytokines in regenerative medicine / E. Ioannidou // Curr. Pharm. Des. - 2006. - Vol. 12, N 19. -P. 2397-2408.
140. Jacobson, K. A. Adenosine receptors as therapeutic targets / K. A. Jacobson, Z. G. Gao // Nat. Rev. Drug Discov. - 2006. - Vol. 5. - P. 247-264.
141. Janson, R. W. Production of IL-I receptor antagonist by human in vitro- derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor / R. W. Janson, K. R. Hance, W. P. Arend // J. Immunol. -1991.-Vol. 147.-P. 4218-4223.
142. Johnston-Cox, J.A. A2 adenosine receptors and vascular pathologies / J. A. Johnston-Cox, M. Koupenova, K. Ravid// Ateroscler. Thromb. Vase. Biol. - 2012. - Vol. 32, N 4. - P. 870-878.
143. Khoa, N.D. Inflammatory cytokines regulate adenosine A2A receptor expression, function, and desensitization / N. D. Khoa // Dissertation (Ph.D.) - New York: UMI Dissertations Publishing. - 2007. - 145 p.
144. Kim, S. U. Stem cell-based cell therapy in neurological diseases: a review /
5. U. Kim, J. de Vellis // J. Neurosci. Res.- 2009. - Vol. 87, N 10. - P. 2183-2200.
145. Kloor, D. S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action / D. Kloor, H. Osswald // Trends Pharmacol. - 2004. - Vol. 25, N
6. -P. 294-297.
146. Kondo, T. Molecular pathology of wound healing / T. Kondo, Y. Ishida // Forensic Science International. - 2010. - Vol. 203, N1-3. - P. 93-98.
147. La Sala5 A. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK / A. Ia Sala5 M. Gadina5 B. L. Kelsall // J. Immunol. - 2005. - Vol. 175, N 5. -P. 2994-2999.
148. Laudadio5 M. A. The A3 adenosine receptor agonist 2-C1-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices / M. A. Laudadio5 C. Psarropoulouc // Epilepsy Res. - 2004. - Vol. 59. - P. 83-94.
149. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes / A. A. Link5 T. Kino5 J. A. Worth et al. // J. Immunol. - 2000.-Vol. 164.-P. 436-442.
150. Linden5 J. Adenosine in tissue protection and tissue regeneration / J. Linden // Mol. Pharmacol. - 2005. - Vol. 67. - P. 1385-1387.
151. Lindvall5 O. Stem cells for the treatment of neurological disorders / O. Lindvall5 Z. Kokaia // Nature. - 2006. - Vol. 441, N 7097. - P. 1094-1096.
152. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-кВ in A2A adenosine receptor induction / L. J. Murphree5 G. W. Sullivan, M. A. Marshall, J. Linden // Biochem. J. - 2005. - Vol. 391, N 3. - P. 575-580.
153. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms / T. Kinnaird5 E. Stabile, M. Burnett et al. // Circulation - 2004. - V. 109, N 12. - P. 1543-1549.
154. Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats / M. Wakeno5 T. Minamino5 O. Seguchi et al. // Circulation. - 2006. - Vol. 114. - P. 1923-1932.
155. LPS-induced cytokine production in human monocytes and macrophages / M. Rossol, H. Heine, U. Meusch et al. // Crit. Rev. Immunol. - 2011. - Vol. 31, N 5. - P. 379-446.
156. Macrophage receptors and immune recognition / P. R. Taylor, L. Martinez- Pomares, M. Stacey et al. // Annu. Rev. Immunol. - 2005. - Vol., N 23. - P. 901— 944.
157. Manera, C. A2Areceptor ligands: past, present and future trends / C. Manera, G. Saccomanni // Curr. Top. Med. Chem. - 2010. - Vol. 10. - P. 902-922
158. Mangoni, M. E. adenosine receptors. Heart rate. And cardioprotection / M. E. Mangoni, S. Barrere-Lemaire // Cardivasc. Res. - 2004. - Vol. 62, P. 447-449.
159. Manjunath, S. Adenosine and adenosine receptors: Newer therapeutic perspective / S. Manjunath, P.M. Sakhare // Indian J. Pharmacol. - 2009. -Vol. 41, N3.-P. 97-105.
160. Mechanisms involved in the therapeutic properties of mesenchymal stem cells / L. da Silva Meirelles, A. M. Fontes, D. T. Covas, A. I. Caplan // Cytokine Growth Factor Rev. - 2009. - Vol. 20. - P. 419-427.
161. Methotrexate enhances the anti-inflammatory effect of CFlOl via up- regulation of the A3 adenosine receptor expression / A. Ochaion, S. Bar- Yehuda, S. Cohn et al. // Arthritis Res. Ther. - 2006. - Vol. 8, N 6. - Rl69.
162. Milne, G. R. Anti-inflammatory and immunosuppressive effects of the A2a adenosine receptor / G. R. Milne, T. M. Palmer // Scientific World Journal. - 2011.-Vol. 11.-P. 320-339.
163. Modulating Alzheimer's disease through caffeine: a putative link to epigenetics / S. Marques, V. L. Batalha, L. V. Lopes, T. F. Outeiro // J. Alzheimers Dis. -2011. - Vol. 24, Suppl. 2. -P. 161-171.
164. Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis / С. M. Forrest, G. Harman, R. B. McMillan et al. // 2005. - Clin. Exp. Rheumatol. - Vol. 23. - P. 89-92
165. Modulation of glial cell functions by adenosine receptors / E. Dare, G. Schulte, O. Karovic et al. // Physiol. Behav. - 2007. - Vol. 92, N 1-2. - P. 15-20.
166. Molecular mechanisms of A3 adenosine receptor-induced Gl cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway / M. Aghaei, M. Panjehpour, F. Karami- Tehrani, S. Salami // J. Cancer Res. Clin. Oncol. - 2011. - Vol. 137, N 10. - P.1511-1523
167. Morelli, M. Adenosine A2A receptors and Parkinson's disease / M. Morelli, A. R. Carta, P. Jenner // Handb. Exp. Pharmacol. - 2009. - Vol. 193. - P. 589-615.
168. Muller, С. E. Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders / С. E. Muller, S. Ferre // Recent. Pat. CNS Drug Discov. - 2007. - Vol. 2, N. I. -P. 1-21.
169. Mullera, С. E. Recent developments in adenosine receptor ligands and their potential as novel drugs / С. E. Mullera, K. A. Jacobson // Biochim. Biophys. Acta.-2011.-Vol. 1808, N 5.-P. 1290-1308.
170. Murphy, M. B. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine / M. B. Murphy, K. Moncivais, A. I. Capla // Exp. Mol. Med. - 2013. - Vol. 45. - P. 54.
171. Okamura, T. Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma / T. Okamura, Y. Kurogi, K. Hashimoto // Bioorg. Med. Chem. Lett. -2004. - Vol. 14. - P. 3775- 3779.
172. Olsen, N. J. Methotrexate induces production of IL-I and IL-6 in the monocytic cell line U937 / N. J. Olsen, C. F. Spurlock, T. M. Aune // Arthritis Res. Ther. -2014. -Vol. 16, N I. -P. 17.
173. Ortore, G. A2B receptor ligands: past, present and future trends / G. Ortore, A. Martinelli // Curr. Top. Med. Chem. - 2010. - Vol. 10, N 9. - P. 923-940.
174. Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease / K. Varani, G. Caramori, F. Vincenzi et al. // The FASEB Journal. - 2010. - V. 24. -P. 1192-1204.
175. Palmer, T. M. Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction / T. M. Palmer, M. A. Trevethick // Br. J. Pharmacol. - 2008. - Vol. 153. - P. 27 - 34.
176. Partial Ai adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF) / J. A. Zablocki, L. Wu, J. Shryock, L. Belardinelli // Curr. Top. Med. Chem. - 2004. - Vol. 4. - P. 839-854.
177. Pawitan J.A. Prospect of stemm cell conditioned medium in regenerative medicine / J.A. Pawtan // BioMed Res. bit. - 2014. - Ш 65849.
178. Perspectives in skin burns / G. D. Mogosanu, F.C. Popescu, C.J. Busuioc et al. // Rom. J. Morphol. Embryol. - 2012. - Vol. 53, N 2. - P. 249-262
179. Pharmacokinetics, pharmacodynamics, and safety of a lipid-lowering adenosine Al agonist, RPR749, in healthy subjects / B. Shah, S. Rohatagi, C. Natarajan et al. // Am. J. Ther. - 2004. - Vol. 11. - P. 175-189.
180. Pharmacological Blockade of A2A Receptors Prevents Dermal Fibrosis in a Model of Elevated Tissue Adenosine / P. Fernandez, S. Trzaska, T. Wilder et al. // Am. J Pathol. - 2008. - Vol. 172, N 6. - P. 1675-1682.
181. Phospholipase C is involved in the adenosine-activated signal transduction pathway conferring protection against iodoacetic acid-induced injury in primary rat neuronal cultures / A. Rogel, Y. Bromberg, O. Sperling, E. Zoref-Shani //Neurosci. Lett. -2005. - Vol. 373. -P. 218-221.
182. Polarized monocyte response to cytokine stimulation / D. Nagorsen, S. Deola, K. Smith et al. // Genome Biology. - 2005. - Vol. 6, N 2. - P. 15
183. Polosa, R. Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation / R. Polosa, S. T. Holgate // Curr. Drug. Targets. - 2006. - Vol. 7. - P. 699-706.
184. Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A2A receptor / A. Bitto, F. Polito, N. Irrera et al. // Arthritis Rheum. - 2011. - Vol. 63. - P. 3364-3371.
185. Postconditioning protects rabbit hearts throught a protein kinase C- adenosine A2B receptor cascade / S. Philipp, X. Yang, L. Cui et al. // Cardiovasc. Res. - 2006. - Vol. 70. - P. 308-314.
186. Potential for developing purinergic drugs for gastrointestinal diseases / F. Ochoa-Cortes, A. Linan-Rico, K. A. Jacobson, F. L. Christofi // Inflamm. Bowel. Dis. - 2014. - Vol. 20, N 7. - P. 1259-1287.
187. Present et fiitur de la therapie cellulaire des brulures / L. Bargues, M. Prat, T. Leclerc et al. // Pathol. Biol. - 2011. - Vol. 59, N 3. - P. 49-56.
188. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood / G. Luo, W. Cheng, W. He et al. // Wound Repair Regen. - 2010. - Vol. 18. - P. 506-513.
189. Purinergic immunodeficiency diseases. Selective toxicity of deoxyribonucleosides for T cells / B. S. Mitchell, E. Mejias, P. E. Daddona, Kelly W. N. // Proc. Nat. Acad. Sci. USA - 1978. - Vol. 75. -P. 5011-5016.
190. Randomized, controlled dose-ranging study of the selective adenosine Агл receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging / J. E. Udelson, G. V. Heller, F. J. Wackers et al. // Circulation. 2004. - Vol. 109. -P. 457^164.
191. Recent developments in A2B adenosine receptor ligands / R. V. Kalla, J. Zablocki, M. A. Tabrizi, P. G. Baraldi // Handb. Exp. Pharmacol. - 2009. -Vol. 193.-P. 99-122.
192. Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine / J. Peart, L. Willems, J. P. Headrick et al. // Am. J. Physiol. Heart. Circ. Physiol. - 2003. - Vol. 284, N 2. - P. 519-527.
193. Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(I) adenosine receptor partial agonist / P. M. Staehr, A. K. Dhalla, J. Zack et al. // J. Clin. Pharmacol. - 2013. - Vol. 53, N 4. - P. 385-392.
194. Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells / Z. Sheng, X. Fu, S. Cai et al. // Wound Repair Regen. - 2009. - Vol. 17, N 3. - P. 427-35.
195. Regulation of adenosine receptor subtypes during cultivation of human monocytes: role of receptors in preventing lipopolysaccharidetriggered respiratory burst /A. Thiele, R. Kronstein, A. Wetzel et al. // Infect. Immun. - 2004. - Vol. 72. -P. 1349-1357.
196. Regulation of neutrophil function by adenosine / K. E. Barletta, K. Ley, B. Mehrad // Arterioscler. Thromb. Vase. Biol. - 2012. - Vol. 32, N 4. - P. 856-864.
197. Rheinwald, J. G. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells / J. G. Rheinwald, H. Green // Cell. - 1975. - Vol. 6, N 3. - P. 331-343.
198. Role of Ai adenosine receptors in the regulation of vascular tone / H. E. Tawfik, J. Schnermann, P. J. Oldenburg, S. J. Mustafa // Am. J. Physiol. Heart Circ. Physiol. - 2005. - Vol. 288. - P. 1411-1416.
199. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in isolated rat heart / E. Hochhauser, O. Eaminski, H. Shalom et al. // Antioxidants & Redox Signaling. - 2004. - Vol. 6, N 2. - P. 335- 344.
200. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart / H. Cho , N. Lee, J. Lee et al. // J Exp Med. - 2007. - V. 204, N 13. - P. 3257-3269.
201. Schulte, G. Adenosine receptor signaling and the activation of mitogen- activated protein kinases / G. Schulte. - Stockholm: Repro Print AB, 2002. - 67 p.
202. Secretion of immunoregulatory cytokines by mesenchymal stem cells / D. Kyurkchiev, I. Bochev, E. Ivanova-Todorova et al. // World J. Stem Cells. - 2014. - Vol. 6, N 5. -P. 552-570.
203. Severe burn injury in europe: a systematic review of the incidence, etiology, morbidity, and mortality / N. Brusselaers, S. Monstrey, D. Vogelaers et al. // Crit. Care. - 2010. - Vol. 14, N 5. - P. 188.
204. Shaping of monocyte and macrophage function by adenosine receptors / G. Hasko, P. Pacher, E. A. Deitch, E. S. Vizib // Pharmacol. Ther. - 2007. - Vol. 113, N2.-P. 264-275.
205. Skouroliakou, M. Caffeine versus theophylline for apnea of prematurity: a randomized controlled trial / M. Skouroliakou, F. Bacopoulou, S. L. Markantonis // J. Paediatr. Child. Health. - 2009. - Vol. 45. - P.587-592.
206. Stanley, A.C. Pathways for Cytokine Secretion / A.C. Stanley, L. Paige // Physiology. - 2010. - Vol. 25, N 4. - P. 218-229.
207. Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease / P. Donndorf, B.E. Strauer, A. Haverich, G. Steinhoff // Curr. Pharm. Biotechnol. - 2013. - Vol. 14, N I. -P. 12-19.
208. Stone, T. W. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration / T. W. Stone, S. Ceruti, M. P. Abbracchio // Handb. Exp. Pharmacol. - 2009. - Vol. 193. - P. 535-87.
209. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis / M. C. Montesinos, A. Desai, B. N. Cronstein // Arthritis Res. Ther. - 2006.-Vol. 8, N 2. -R53
210. Svensjo, T. Autologous keratinocyte suspensions accelerate epidermal wound healing in pigs / T. Svensjo, F. Yao, B. Pomahac, E. Eriksson // J. Surg. Res.-2001.-Vol. 99.-P.211-21
211. Sykes, M. Treatment of severe autoimmune disease by stem-cell transplantation / M. Sykes, B. Nikolic // Nature. - 2005. - Vol. 435, N 7042. - P. 620-627.
212. Synergic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via hypoxia response element in the VEGF promoter / M. Ramanathan, G. Pinhal-Enfield, I. Hao, S. Leibovich // Mol. Biol. Cell.-2007.-Vol. 18, N I. -P. 14-23.
213. The A2A adenosine receptor controls cytokine production in iNKT cells / M. Nowak, L. Lynch, S. Yue et al. // Eur. J. Immunol. - 2010. - Vol. 40. - P. 682- 687.
214. The A2aR adenosine receptoe controls cytokine production in iNKT cells / M. Nowak, L. Lynch, S. Yue et al. // Eur. J. Immunol. - 2010. - Vol. 40. - P. 682- 687.
215. The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells / J. M. Wilson, W. G. Ross, O. N. Agbai, et al. // J. Immunol. - 2009. - Vol. 182. - P. 4616 - 4623.
216. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice / M.C. Montesinos, M. Takedachi, L.F. Thompson et al. // Arthritis Rheum. - 2007. - Vol. 56, N 5. - P.1440-1445.
217. The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure / H. Yang, M. Y. Avila, K. Peterson-Yantomo et al. // Curr. Eye Res. - 2005. - Vol. 30. - P. 747-754.
218. The role of adenosine A2A and A2B receptors in the regulation of TNF- alpha production by human monocytes / J. G. Zhang, L. Hepburn, G. Cruz et al. // Biochem. Pharmacol. - 2005. - Vol. 69. -P. 883-889.
219. The role of adenosine receptors in regulating production of tumour necrosis factor-а and chemokines by human lung macrophages / A. Buenestado, S. Grassin Delyle, I. Arnould et al. // Br. J. Pharmacol. - 2010. - Vol. 159, N 6. - P. 1304- 1311.
220. Thirabanj asak, D. Angiomyeloproliferative lesions following autologous stem cell therapy / D. Thirabanjasak, K. Tantiwongse, P. S. Thomer // J. Am. Soc. Nephrol. -2010. - Vol. 21. -P. 1218-1222.
221. Tian H. Understanding the mechanisms of action methotrexat / H. Tian, B.N Cronstein // Bulletin of the NYU hospital for joint diseases. - 2007. - Vol. 65, N 3. -P. 168-173.
222. Total Burn Care / Herndon DN, editor. - 3rd edition. - Philadelphia: Saunders Elsevier, 2007. - 749 p.
223. Transcriptional profiles during the differentiation and maturation of monocyte-derived dendritic cells, analyzed using focused microarrays / W. Zhong, M. Fei, Y. Zhu, X. Zhang // Cell mol. Biol. Lett. - 2009. - Vol. 14, N 4. - P. 587- 608.
224. Transforming growth factor beta I functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms / J. Turley, L. Falk, F. Ruscetti et al. // Cell Growth Differentiation. - 1996. - Vol. 7. - P. 1535- 1544
225. Treatment of dry eye syndrome with orally-administered CFlOl: data from a phase 2 clinical trial /1. Avni, H. J. Garzozi, I. S. Barequet et al. // Ophthalmology. -2010.-Vol. 117.-P. 1287-1293.
226. Treatment of plaque-type psoriasis with oral CFlOl: data from an exploratory randomized phase 2 clinical trial / M. David, L. Akerman, M. Ziv et al. // J. Eur. Acad. Dermatol. Venereol. - 2012. - Vol. 26, N 3. - P. 361-367.
227. Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance / S. Danese, N. Pagano, E. Angelucci et al. // Curr. Med. Chem. - 2007. - Vol. 14, N 14. - P.1489-1497.
228. Vails, M. D. Adenosine receptor agonists for promotion of dermal wound healing / M. D. Vails, B. N. Cronstein, M. C. Montesinos // Biochem. Pharmacol. - 2009. -VoL 77.-P. 1117-1124
229. Wakade A. R. Intracellular, nonreceptor-mediated signaling by adenosine: induction and prevention of neuronal apoptosis / A. R. Wakade, D. A. Przywara, T. D. Wakade // Mol. Neurobiol. - 2001. - Vol. 23, N 2-3. - P. 137-153.
230. Wakade, A. R. 2'-Deoxyadenosine selectively kills nonneuronal cells without affecting survival and growth of chick dorsal root ganglion neurons / A. R. Wakade, J. S. Kulkarni, J. T. Fujii // Brain Res. - 1998. - Vol. 788. - P. 69-79.
231. Wilson, C. N. Adenosine receptors and asthma in humans / C. N. Wilson // Br. J. Pharmacol. - 2008. - Vol. 155. - P. 475-486.
232. Wilson, C.N. Adenosine receptors in health and disease / C.N. Willson, S.J. Mustafa // Handbook of Experimental Pharmacology - Berlin: Springer-Verlag. 2009. - Vol. 193.-652 p.
233. Wood, F. M. The use of cultured epithelia autograft in the treatment of major burn wounds: Eleven years of clinical experience / F. M. Wood, M. L. Kolybaba, P. Allen // Burns. - 2006. - Vol. 32. - P. 538-544.
234. Wood, F. M. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature / F. M. Wood, M. L. Kolybaba, P. Allen // Burns. - 2006. -.Vol. 32. - P. 395-401.
235. Ye, J.H. Adenosine: an immune modulator of inflammatory bowel diseases / J. H. Ye, V. M. Rajendran // World J. Gastroenterol. - 2009. - Vol. 15, N 36, P. 4491-4498.
236. Zhang, Z. Tissue engineered human skin equivalents / Z. Zhang, В. B. Michniak-Kohn // Pharmaceutics. - 2012. - Vol. 4. - P. 26-41.
237. Zhou, Y. Adenosine signaling and the regulation of chronic lung disease / Y. Zhou, D. J. Schneider, M. R. Blackburn // Pharmacol. Ther. - 2009. - Vol. 123, N l.-P. 105-116.